Analysts Set Theravance Biopharma, Inc. (NASDAQ:TBPH) PT at $11.33
Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) has been given an average rating of “Moderate Buy” by the five brokerages that are currently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, one has given a buy recommendation and one has assigned a strong buy recommendation to […]
Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) has been given an average rating of “Moderate Buy” by the five brokerages that are currently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, one has given a buy recommendation and one has assigned a strong buy recommendation to […]
